NCT02921997 H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses Status COMPLETED Phase PHASE2
NCT02918006 A Phase 2 Influenza A Challenge Study Following Oral Administration of an H1N1 HA Ad-Vector Seasonal Flu Vaccine Status COMPLETED Phase PHASE2
NCT02915302 Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children Status COMPLETED Phase PHASE4
NCT02908269 Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines, 2016-2017 Formulations Status COMPLETED Phase PHASE4
NCT02894840 Safety and Immunogenicity of GPO Seasonal Trivalent Inactivated Influenza Vaccine in Healthy Thai Adults Status COMPLETED Phase PHASE1/PHASE2
NCT02883426 Evaluating the Safety and Immunogenicity of a Live Attenuated Virus Vaccine to Prevent Influenza H3N2v Disease Status TERMINATED Phase PHASE1
NCT02877160 A Study to Assess the PK of AL-794 Formulations in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02876159 The Immunologic Basis for an Attenuated Immune Response to the Influenza Vaccine After Repeated Annual Vaccination Status COMPLETED Phase PHASE4
NCT02871206 Adjuvanted Inactivated Vaccine Versus Inactivated Influenza Vaccine in Hutterite Children Status COMPLETED Phase PHASE4
NCT02860039 High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant Status COMPLETED Phase PHASE2
NCT02846311 Evaluation of the Alere i Influenza A&B Nucleic Acid Amplification Versus Xpert Flu/RSV Status COMPLETED Phase N/A
NCT02819180 Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine - FLU-02-IB Status COMPLETED Phase N/A
NCT02819115 Cohort Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine Status COMPLETED Phase N/A